Beyond Counting: New Way To Use Circulating Tumor Cells
نویسندگان
چکیده
منابع مشابه
Beyond counting: new way to use circulating tumor cells.
In 2007, researchers at Boston’s Massachusetts General Hospital (MGH) Cancer Center showed that a microfluidic device, the CTC-Chip, could separate and count rare circulating tumor cells (CTCs) in wholeblood samples (Nature 2007;450:1235–9). Last year, the team developed the CTCiChip, a refined version of its predecessor, and confirmed its utility in catching viable CTCs. This device can profil...
متن کاملFISH Probe Counting in Circulating Tumor Cells
Presence of tumor cells in blood of patients with metastatic carcinomas has been associated with poor progression free and overall survival (Cohen et al., 2008; Cristofanilli et al., 2004; de Bono et al., 2008). Assessment of treatment targets on circulating tumor cells (CTC) before initiation of therapy may provide a means to guide therapy (Attard et al., 2009; de Bono et al., 2007; Hayes et a...
متن کاملCirculating Tumor Cells, Enumeration and Beyond
The detection and enumeration of circulating tumor cells (CTCs) has shown significant clinical utility with respect to prognosis in breast, colorectal and prostate cancers. Emerging studies show that CTCs can provide pharmacodynamic information to aid therapy decision making. CTCs as a 'virtual and real-time biopsy' have clear potential to facilitate exploration of tumor biology, and in particu...
متن کاملCirculating tumor cells--new challenges ahead.
The presence of circulating tumor cells (CTCs) was first described by Thomas Ashworth in 1869 (1 ). In 1889, Stephen Paget proposed in the first issue of The Lancet the “seed and soil” hypothesis, according to which “metastasis depends on cross talk between selected cancer cells and specific organ microenvironment,” a hypothesis revisited many years later by Isaiah Fidler (2 ). It took more tha...
متن کاملCirculating tumor cells in prostate cancer: beyond enumeration.
Circulating tumor cells (CTCs) are a population of rare cancer cells that have detached from the primary tumor and/or metastatic lesions and entered the peripheral circulation. Enumeration of CTCs has demonstrated value as a prognostic biomarker, and newer studies have pointed to information beyond enumeration that is of critical importance in prostate cancer. Technologic advances that permit e...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI: Journal of the National Cancer Institute
سال: 2014
ISSN: 1460-2105,0027-8874
DOI: 10.1093/jnci/dju343